0001209191-22-055407.txt : 20221102 0001209191-22-055407.hdr.sgml : 20221102 20221102190949 ACCESSION NUMBER: 0001209191-22-055407 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221031 FILED AS OF DATE: 20221102 DATE AS OF CHANGE: 20221102 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Azelby Robert CENTRAL INDEX KEY: 0001656998 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40708 FILM NUMBER: 221355661 MAIL ADDRESS: STREET 1: 307 WESTLAKE AVE. NORTH, STE 300 CITY: SEATTLE STATE: WA ZIP: 98109 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Eliem Therapeutics, Inc. CENTRAL INDEX KEY: 0001768446 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 832273741 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 23515 NE NOVELTY HILL ROAD STREET 2: SUITE B221 #125 CITY: REDMOND STATE: WA ZIP: 98053 BUSINESS PHONE: 425-276-2300 MAIL ADDRESS: STREET 1: 23515 NE NOVELTY HILL ROAD STREET 2: SUITE B221 #125 CITY: REDMOND STATE: WA ZIP: 98053 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-10-31 0 0001768446 Eliem Therapeutics, Inc. ELYM 0001656998 Azelby Robert C/O ELIEM THERAPEUTICS, INC. 23515 NE NOVELTY HILL RD, STE. B221 #125 REDMOND WA 98053 1 1 0 0 President & CEO Stock Option (Right to Buy) 3.27 2022-10-31 4 A 0 500000 0.00 A 2032-10-30 Common Stock 500000 500000 D The shares subject to this option shall vest in equal monthly installments, at a rate of 1/48th of the total number of shares on each monthly anniversary of October 31, 2022 (the "2022 Vesting Commencement Date") for so long as the Reporting Person provides continuous service to the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the 2022 Vesting Commencement Date. /s/ Alan Hambelton, Attorney-in-Fact 2022-11-02